Date: {{$ActivityAssignDate}}

Dear Dr. {{$doctorName}},


Subject : Multicentre, Observational survey to generate insights on diagnosis & management in Dry eye disease


Dry eye disease (DED), commonly known as dry eye syndrome or keratoconjunctivitis sicca (KCS), is one of the leading reasons for patients to seek help from an ophthalmologist. The Tear Film and Ocular Surface Society Dry Eye Workshop II defines a dry eyes as: "Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film minstability and hyperosmolarity, ocular surface infiammation and damage, and neurosensory abnormalities play etiologic roles."


This condition has a complex etiology, with ocular, anatomical, and systemic factors all playing significantly roles. It's crucial to conduct a comprehensive evaluation of patients presenting with symptoms, as timely intervention can greatly enhance their long-term quality of life, provide relief from the discomfort of dry eyes, and yield better treatment results.


Approximately 344 million people worldwide suffer from dry eyes. Compared to the global average, India has a significantly higher incidence of dry eye disease (DED), with rates varying between 18.4% and 54.3%. Symptoms of DED, such as tearing, sensitivity to light, a burning sensation, and a gritty feeling, can negatively impact a patient's quality of life. Additionally, It's been noted that dry eyes becomes increasingly prevalent with age. Research suggests that between 50% and 70% of cataract patients also suffer from DED or another ocular surface disease.


The management of dry eye syndrome is typically carried out using a step-by-step method, which can be adjusted based on the severity of the condition. The first steps involve educating the patient about the disease, modifying their environment (such as reducing exposure to direct high airflow/fans, limiting screen time, and using a humidifier), and identifying and removing any topical and systemic agents that may be contributing to the condition. Topical ocular lubricants, lid hygiene practices (including warm compresses and lid scrubs), and oral essential fatty acids are also part of the initial treatment approach.

Yours truly,


Sun Pharma Laboratories Ltd Mumbai